Unique distribution of programmed death ligand 1 (PD-L1) expression in East Asian non-small cell lung cancer.
CONCLUSIONS: This study revealed the unique distribution of PD-L1 expression in East Asian NSCLCs, which is largely different from Western populations. Since the high response rate of pembrolizumab in the treatment of lung cancer patients with PD-L1 TPS ≥50%, this result indicates that prospective PD-L1 expression testing in specific East Asian patients could facilitate decision making for immunotherapy.
PMID: 28932565 [PubMed]
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Smokers | Squamous Cell Carcinoma | Study